Ve Psyb News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ve psyb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ve Psyb Today - Breaking & Trending Today

PsyBio Therapeutics Corp files provisional patent for producing psilocybin with the US Patent and Trademark Office


PsyBio Therapeutics files provisional patent for producing psilocybin with the US Patent and Trademark Office
The filing increases the company s licensed patent portfolio to four pending provisional patents and one pending non-provisional patent with the US Patent and Trademark Office
The patent application was titled Optimized Methods for the Production of Psilocybin and its Intermediates or Side Products
PsyBio Therapeutics Corp (CVE:PSYB) (OTCPINK:PSYBF) said it has filed a provisional patent application with the US Patent and Trademark Office (USPTO), titled Optimized Methods for the Production of Psilocybin and its Intermediates or Side Products .
The filing increases the company s licensed patent portfolio to four pending provisional patents and one pending non-provisional patent with the USPTO, PsyBio said, as it builds a platform around bacterial-based synthesis of therapeutic tryptamines, a class of hallucinogens.  ....

Michael Spigarelli , Evan Levine , Trademark Office , Psybio Therapeutics Corp , Drug Administration , Mcmurray Labs At Miami University , Optimized Methods , Bio Therapeutics , Mcmurray Labs , Miami University , Harma Biotech , Psybio Therapeutics , Ve Psyb , மைக்கேல் ஸ்பிகரெல்லி , எவன் லெவின் , முத்திரை அலுவலகம் , உயிர் சிகிச்சை , மியாமி பல்கலைக்கழகம் ,

PsyBio Therapeutics Corp and Miami University broaden partnership agreement to advance its neuropsychiatric drug discovery platform


PsyBio and Miami University broaden partnership agreement to advance its neuropsychiatric drug discovery platform
The McMurray Lab in Miami University plans to conduct IND-enabling, animal studies to verify the antidepressant, anti-addictive effects of the alkaloids produced in the Jones Lab
The collaboration with Miami University is “anticipated to expediate progress towards the filing of an IND application with the US FDA
PsyBio Therapeutics Corp (CVE:PSYB) (FRA:PSYB) announced that it has amended its master-sponsored agreement with Miami University based in Oxford, Ohio for the continued advancement of its neuropsychiatric drug discovery platform. 
The Coconut Creek, Florida-based biotechnology company pioneering the next generation of targeted psychoactive medications, explained that the move expanded the research efforts of Dr J Andrew Jones’ lab in the Department of Chemical, Paper, and Biomedical Engineering, to include additional research ....

United States , Coconut Creek , Miami University , J Andrew Jone , Matthew Mcmurray , Evan Levine , Mcmurray Lab , Department Of Psychology , Jones Lab , Drug Administration , Psybio Therapeutics Corp , Department Of Chemical , Professor At Miami University , Biomedical Engineering , Investigational New Drug , Scientific Advisory Board , Assistant Professor , Harma Biotech , Psybio Therapeutics , Ve Psyb , ஒன்றுபட்டது மாநிலங்களில் , தேங்காய் க்ரீக் , மியாமி பல்கலைக்கழகம் , மேத்யூ மக்மரே , எவன் லெவின் , துறை ஆஃப் உளவியல் ,